Comparison of Intravesical Hyaluronic Acid, Chondroitin Sulfate, and Combination of Hyaluronic Acid-Chondroitin Sulfate Therapies in Animal Model of Interstitial Cystitis
Open Access
- 31 March 2021
- journal article
- research article
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 25 (1), 42-50
- https://doi.org/10.5213/inj.1938176.088
Abstract
Purpose: Three intravesical treatment agents were compared in an interstitial cystitis rat model: chondroitin sulfate, hyaluronic acid, and combined hyaluronic acid-chondroitin sulfate. Methods: Thirty-five female rats were divided into 5 groups: control (group I), isotonic (group II), chondroitin sulfate (group III), hyaluronic acid (group IV), and hyaluronic acid-chondroitin sulfate (group V). Chemical cystitis was induced in all experimental groups by intravesical instillation of 1 mL of hydrogen peroxide (H2O2) for 15 minutes via the transurethral route. The treatment was administered every other day for 3 sessions 2 days after inducing chemical cystitis. Groups II, III, IV, and V received 1 mL of 0.9% NaCl, 1 mL of 0.2% sodium chondroitin sulfate, 1 mL of low-molecular-weight hyaluronic acid, and 1 mL of 2% sodium chondroitin sulfate+ 1.6% sodium hyaluronic acid, respectively. On day 7, the animals were sacrificed and the bladders were removed for histopathological and immunohistochemical assessments. Results: Significant between-group differences were found in vascular congestion (P= 0.006). The grade of submucosal edema in groups II and IV was significantly higher than in group I (P= 0.006, P= 0.006, respectively). In group I, the grade of granulation tissue was lower than the other 4 groups, but no significant difference was found between the remaining groups (P= 0.016). Neutrophil cell infiltration was more intense in groups II and IV than in group I (P= 0.006, P= 0.006, respectively). Significant differences in the leukocyte and mast cell count were detected between groups II and IV (P< 0.001, P< 0.001, respectively). Abnormal zonula occludens-1 and uroplakin-III immunoreactivity in group II was higher than in groups I, III, or V (P= 0.002, P= 0.010, respectively). Interleukin-8 expression was lower in group V than in group II (P= 0.001). Conclusion: A single treatment of chondroitin sulfate and combined hyaluronic acid-chondroitin sulfate treatment demonstrated efficacy by suppressing inflammation and achieving improvements in the urothelium.Keywords
This publication has 30 references indexed in Scilit:
- Intravesical Chondroitin Sulfate Inhibits Recruitment of Inflammatory Cells in an Acute Acid Damage “Leaky Bladder” Model of CystitisUrology, 2012
- Uroplakins in urothelial biology, function, and diseaseKidney International, 2009
- Cell signaling in interstitial cystitis/painful bladder syndromeCellular Signalling, 2008
- Urine Markers Do Not Predict Biopsy Findings or Presence of Bladder Ulcers in Interstitial Cystitis/Painful Bladder SyndromeJournal of Urology, 2008
- Influence of the glycosaminoglycan layer on the permeation of hypericin in rat bladders in vivoBJU International, 2007
- The Interstitial Cystitis Syndrome: Intravesical and Oral TreatmentEuropean Urology Supplements, 2003
- A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitisUrology, 1996
- Cytokines involved in growth and differentiation of human basophils and mast cellsExperimental Dermatology, 1995
- Activation of Bladder Mast Cells in Interstitial Cystitis: A Light and Electron Microscopic StudyJournal of Urology, 1995
- Activation of Bladder Mast Cells in Interstitial CystitisJournal of Urology, 1995